Mutant glutamate-cysteine ligase and method for manufacturing gamma glutamyl-valyl-glycine
US10113161B2 · kind B2 · utility
1Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2016 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Sep 21, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y603/02002
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A mutant glutamate-cysteine ligase (GSHA) suitable for generating γ-Glu-Val, and a method for producing γ-Glu-Val-Gly using the same are provided. γ-Glu-Val is produced by using a mutant GSHA having a specific mutation with Glu and Val as raw materials, and γ-Glu-Val-Gly is further produced by using γ-Glu-Val and Gly as raw materials. γ-Glu-Val-Gly is produced by using a mutant GSHA having a specific mutation with Glu, Val, and Gly as raw materials.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.